Heidelberg Pharma AG (HPHA) — Defensive Interval Ratio

Latest as of May 2025: 1 days

Heidelberg Pharma AG (HPHA) has a Defensive Interval Ratio of 1 days as of May 2025. Defensive assets of €12.87K (cash €-, short-term investments €-, receivables €12.87K) cover 1 days of daily cash needs of €17.42K/day. See HPHA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

1 days
Days of operational coverage

Defensive Assets

€12.87K
Cash + ST Investments + Receivables

Daily Cash Need

€17.42K
Current Liabilities ÷ 365

Current Liabilities

€6.36 Million
EUR

Heidelberg Pharma AG Defensive Interval Ratio (2016–2024)

This chart shows how Heidelberg Pharma AG's Defensive Interval Ratio has evolved across 9 annual periods from 2016 to 2024. As of May 2025, the ratio stands at 1 days, meaning defensive assets of €12.87K can fund 1 days of operations without new revenue. See Heidelberg Pharma AG balance sheet independence to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Heidelberg Pharma AG (2016–2024)

The table below presents the year-by-year Defensive Interval Ratio for Heidelberg Pharma AG from 2016 to 2024, covering 9 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of Heidelberg Pharma AG.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2024 13 days €284.00K €21.91K/day €- €- ▼ -5 days
2023 18 days €979.00K €54.18K/day €- €- ▲ +5 days
2022 13 days €973.00K €76.53K/day €- €- ▼ -12 days
2021 25 days €1.02 Million €40.92K/day €- €- ▼ -40 days
2020 65 days €1.19 Million €18.16K/day €- €- ▼ -14 days
2019 80 days €1.41 Million €17.70K/day €- €- ▲ +37 days
2018 42 days €614.68K €14.54K/day €- €- ▲ +2 days
2017 40 days €494.39K €12.21K/day €- €- ▲ +28 days
2016 12 days €183.38K €15.01K/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)